The company's debt is viewed as a risk due to its negative E...
The company's debt is viewed as a risk due to its negative EBIT and significant revenue drop. The balance sheet is deemed unfit and the stock is considered highly risky. The company's use of debt, considering its liabilities and negative earnings, raises concerns.
Here's Why Luoxin Pharmaceuticals Group Stock (SZSE:002793) Can Afford Some Debt
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment